Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905718-22-000342
Filing Date
2022-02-14
Accepted
2022-02-14 16:14:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A volitionrx_13gam1dec312021.htm SC 13G/A 37004
  Complete submission text file 0000905718-22-000342.txt   38673
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Subject) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78472 | Film No.: 22632075
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2215 NEW YORK NY 10019 212-309-7664
Lagoda Investment Management, L.P. (Filed by) CIK: 0001632108 (see all company filings)

EIN.: 464740139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A